Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3383203 | Reumatología Clínica | 2012 | 4 Pages |
Abstract
Currently, the measurement of bone remodeling biomarkers is an innovate proposal in clinical evaluation of patients with osteoporosis. Its use may identify patients at increased risk of fracture as well as monitoring therapeutic efficacy. Because they constitute a relatively inexpensive non-invasive measurement, its use should be widespread for serial and frequent measurements of bone turnover. However, their analytical and biological variability limits their clinical applicability.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Carmen M. Romero Barco, Sara Manrique Arija, Manuel RodrÃguez Pérez,